Home/Hedge Fund Intelligence/Kymera Therapeutics, Inc.
Nasdaq: KYMRStockForm 13F30 Jun 2026

Hedge funds that hold Kymera Therapeutics, Inc. Nasdaq: KYMR

CUSIP 501575104 · who reports it, how much, and how much it matters to them

29 of the 720 hedge fund managers we track reported shares of Kymera Therapeutics, Inc. (Nasdaq: KYMR) on Form 13F for 30 June 2026. Between them they reported USD 2.3bn. The largest position belongs to Baker Bros. Advisors, at USD 993m. The manager with the most riding on it is Avoro Capital Advisors, where it is 7.7% of the reported book.

Managers reporting it29of 720 we track
Value they reportUSD 2.3bnshares only, 30 Jun 2026
Funds they run389with a file on PPLI.com
Largest positionUSD 993mBaker Bros. Advisors
Typical weight0.2%median share of a manager's book
Heaviest weight7.7%Avoro Capital Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

29 managers, USD 2.3bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Kymera Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Baker Bros. Advisors2 funds on PPLI.comUSD 993m5.0%
2Avoro Capital Advisors1 fund on PPLI.comUSD 857m7.7%
3Holocene Advisors2 funds on PPLI.comUSD 73m0.2%
4Rock Springs Capital Management2 funds on PPLI.comUSD 52m2.5%
5Boxer Capital Management1 fund on PPLI.comUSD 49m3.7%
6Braidwell12 funds on PPLI.comUSD 43m1.6%
7Two Sigma Investments35 funds on PPLI.comUSD 43m0.0%
8Octagon Capital Advisors1 fund on PPLI.comUSD 36m3.2%
9RTW Investments2 funds on PPLI.comUSD 28m0.2%
10Polar Capital LLP26 funds on PPLI.comUSD 23m0.1%
11Adage Capital Management1 fund on PPLI.comUSD 23m0.0%
12Marshall Wace LLP84 funds on PPLI.comUSD 19m0.0%
13Eagle Health Investments1 fund on PPLI.comUSD 19m3.2%
14Boone Capital Management1 fund on PPLI.comUSD 13m3.0%
15Citadel Advisors32 funds on PPLI.comUSD 13m0.0%
16Armistice Capital1 fund on PPLI.comUSD 12m0.1%
17Atika Capital Management3 funds on PPLI.comUSD 12m0.8%
18Squarepoint Ops7 funds on PPLI.comUSD 11m0.0%
19Burkehill Global Management5 funds on PPLI.comUSD 8.6m0.3%
20Yiheng Capital Management1 fund on PPLI.comUSD 7.3m2.5%
21Dafna Capital Management6 funds on PPLI.comUSD 3.1m0.6%
22Freestone Grove Partners1 fund on PPLI.comUSD 2.4m0.0%
23Scientech Research2 funds on PPLI.comUSD 1.5m1.2%
24Brandywine Managers47 funds on PPLI.comUSD 868,0000.4%
25HighVista Strategies27 funds on PPLI.comUSD 428,0000.1%
26D. E. Shaw & Co.15 funds on PPLI.comUSD 321,0000.0%
27CIBC Asset Management69 funds on PPLI.comUSD 289,0000.0%
28Bayforest Capital1 fund on PPLI.comUSD 108,0000.1%
29The Quarry1 fund on PPLI.comUSD 1,0320.0%
Next: where it matters most
Where it matters most

For Avoro Capital Advisors it is 7.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Avoro Capital AdvisorsUSD 857m7.7%
2Baker Bros. AdvisorsUSD 993m5.0%
3Boxer Capital ManagementUSD 49m3.7%
4Octagon Capital AdvisorsUSD 36m3.2%
5Eagle Health InvestmentsUSD 19m3.2%
6Boone Capital ManagementUSD 13m3.0%
7Rock Springs Capital ManagementUSD 52m2.5%
8Yiheng Capital ManagementUSD 7.3m2.5%
9BraidwellUSD 43m1.6%
10Scientech ResearchUSD 1.5m1.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Kymera Therapeutics, Inc.

What is the ticker symbol of Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. trades under the symbol KYMR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 501575104.

Which hedge funds own Kymera Therapeutics, Inc. (Nasdaq: KYMR)?

29 of the 720 hedge fund managers PPLI.com tracks reported Kymera Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 993m), Avoro Capital Advisors (USD 857m), Holocene Advisors (USD 73m), Rock Springs Capital Management (USD 52m) and Boxer Capital Management (USD 49m).

How many hedge funds hold Kymera Therapeutics, Inc.?

29 managers in our coverage reported it, and between them they run 389 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Kymera Therapeutics, Inc.?

Avoro Capital Advisors, where the position was 7.7% of the reported 13F book at 30 June 2026.

Does this show who is short Kymera Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Kymera Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.